ECT: AN INNOVATIVE TUMOR TREATMENT

Electrochemotherapy (ECT) is a relatively new treatment that has been proven to show a complete response in the elimination of tumors in companion animals.

RXVET TK-1: AN EASY-TO-USE ECT DEVICE

Portable and affordable, the RXVET TK-1 is now available in the US for the effective treatment of tumors as a part of adjuvant, neoadjuvant, or palliative care in horses, dogs, and cats.

WHY USE ECT: SEE WHAT VETS ARE SAYING

Numerous studies have proven both the efficacy and safety of electrochemotherapy in the treatment of cancerous tumors in equine, feline, and canine subjects in the US and abroad.

Treating Tumors in

Companion Animals

The incidence of cutaneous and subcutaneous cancerous tumors in companion animals has steadily grown over the years, which can lead to shortened lifespans and a reduced quality of life. Treatment of these tumors has traditionally been limited to surgery, chemotherapy, radiation, or a combination of these options.

However, due to location or growth patterns, some tumors cannot be treated by these methods. Electrochemotherapy (ECT) is a safe and effective alternative to these traditional methods that does not involve surgery and in many instances works with a single treatment

female vet with a dog

RXVET TK-1

A New Way to Treat Tumors

  • Easy-to-use ECT device designed specifically for veterinary care
  • Treats many types of tumors in horses, dogs, and cats
  • Allows for the enhanced delivery of chemotherapy and increased drug absorption
  • Proven efficacy with high success rates and low reoccurrence rates
  • No or minimal systemic side effects
  • Can be repeated with equal or improved efficacy
  • Covered by many pet health insurance companies as a cancer treatment

PORTABLE, AFFORDABLE

AND EFFECTIVE

RXVET Biotech is the only US based distributor of RXVET TK-1, an ECT device that has proven efficacy, is safe for animals, is easy-to-use, and does not need special training to operate.

97.9
Complete response rate in sarcoid tumors after 4 years in horses

87.5
Objective response rate in squamous cell carcinoma after 3 years in cats

62.5
Complete response rate in mast cell tumors* after 3 years in dogs

What the Experts

are Saying


HAVE

 QUESTIONS?

  • Contact our customer support team if you have any questions.

©RXVET Biotech 2018 – All rights reserved.